Objectives: The aim of this article is biochemical and kinetic characterization of CTX-M-43, a natural Asp-240!Gly mutant of CTX-M-44 (ex Toho-1), from a clinical isolate of Acinetobacter baumannii isolated in a Bolivian hospital.
Introduction
Nowadays, it is well established that the production of acquired b-lactamases is the predominant cause of resistance to oxyimino-cephalosporins in Gram-negative bacteria. Most of them, belonging to class A extended-spectrum b-lactamases (ESBLs), were derived from TEM-or SHV-type b-lactamases through several mutations, ascribed mainly to a selective pressure induced by extensive use, and sometimes abuse and misuse of b-lactam antibiotics. 1 -4 Among class A b-lactamases, CTX-M ESBLs have an efficient hydrolytic activity towards oxyimino cephalosporins, but exhibit lower activity towards penicillins than non-ESBL enzymes. With this respect, they are characterized by a much greater hydrolytic activity against cefotaxime than ceftazidime and by a different profile to inhibitors. 5, 6 Also among CTX-M enzymes, the spectrum of activity is unusually heterogeneous. These enzymes have unique amino acid sequences, with only 40% identity with other class A b-lactamases. In the last years, the rate of dissemination of CTX-M-type enzymes has increased significantly in clinical isolates of Gram-negative bacteria. 5 To date, the CTX-M family comprises 69 enzymes spread worldwide and divided into six clusters based on their amino acid sequence similarities. 5, 6 Less than 90% of the identity is observed between members belonging to distinct clusters. In 1995, Ishii et al. 7 reported the identification of a new non-TEM and non-SHV cephalosporinase designed as Toho-1, recently renamed CTX-M-44, belonging to the CTX-M-2 cluster. With respect to other CTX-M members, Toho-1 shows a lower hydrolytic activity against penicillins and a higher activity against cefotaxime.
The crystal structure of Toho-1 8, 9 showed an overall fold similar to non-ESBLs. However, an increase in flexibility of the b-strand B3 and V loop and the residues Asn-104, Phe-167, Ser-237, Asp-240 and Arg-276 are involved in the oxyiminocephalosporin hydrolysing activity. 8 -11 Asp-240 !Gly mutants  of CTX-M, CTX-M-15,  12 CTX-M-16,  13 CTX-M-27  14 and  CTX-M-32 15 recently described, exhibit an increased enzymatic activity against ceftazidime. The appearance of Asp-240!Gly mutants in CTX-M-type enzymes with improved catalytic efficiency against ceftazidime suggests that those enzymes are evolving as a result of selective pressure caused by the extensive use of ceftazidime in clinical therapy. The peculiarity of the residues involved in this evolution suggests the potential of those enzymes under an evolutionary standpoint.
Materials and methods

Bacterial strains
bla CTX-M-43 was identified in a clinical isolate of Acinetobacter baumannii (SJ-0008), as reported previously. 16 The organism was isolated from the sputum of a 42-year-old patient from the intensive care unit of the Hospital Municipal Universitario San Juan de Dios in Santa Cruz de la Sierra, Bolivia. Molecular analysis of the A. baumannii isolate showed the simultaneous presence of bla CTX-M and bla TEM-1 genes.
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PCR and DNA sequence analysis
Amplification of the entire bla CTX-M gene was performed using the following specific primers for bla CTX-M-2 genes: CTX-M/B_for 5 0 -ATGATGACTCAGAGCATTCGCCGCT-3 0 and CTX-M/B_rev 5 0 -TCAGAAACCGTGGGTTACGATTTTCG -3 0 . The DNA sequence was determined by direct sequencing of the products from two independent PCRs, using ABI Prism 310 (Applied Biosystems, Monza, Italy). The deduced amino acid sequence showed the presence of an Asp-240!Gly amino acid substitution with respect to CTX-M-44 (ex Toho-1) (GenBank accession number D37830). In accordance with Bush and Jacoby nomenclature (www.lahey.org), the new enzyme was named CTX-M-43 (GenBank accession number DQ102702).
Cloning in expression vector
Primers for PCR cloning into the pBC-SK(þ) vector were designed inserting upstream a XhoI restriction site before the initial methionine and downstream a BamHI site after the stop codon of bla CTX-M-43 . Cloning into the pET-26(b) vector has been performed inserting upstream a NdeI restriction site before the initial methionine and a 
Antibiotics
The following antibiotics were used. 
In vitro susceptibility test
The determination of MICs for E. coli HB101 pBC-SK(þ)/ CTX-M-43 and E. coli HB101 was performed by the conventional macrodilution broth procedure using a bacterial inoculum of 5 Â 10 5 cfu/mL, as recommended by the CLSI. 17 To evaluate the effect of inoculum on MICs, an in vitro susceptibility test was performed using a bacterial inoculum of 5 Â 10 8 cfu/mL.
Production and purification of CTX-M-43 b-lactamase
An overnight culture of E. coli BL21 pET-26(b)(þ)/CTX-M-43 grown in Luria-Bertani broth was diluted 10-fold with 6 L of the same medium containing kanamycin (50 mg/L). The crude extract was prepared as described previously. 18 The first step of purification was performed in a Sepharose S fast-flow column, as described previously. 19 Fractions containing b-lactamase activity were pooled, concentrated 20-fold using an Amicon concentrator (YM 10 membrane; Millipore, Bedford, MA, USA) and loaded onto a Superose 12 column (GE Healthcare, Milan, Italy) pre-equilibrated with 50 mM Tris-HCl buffer pH 7.0. Elution was performed with the same buffer at a flow rate of 1.0 mL/min. The total protein concentration was determined by the method of Bradford, 20 with bovine serum albumin (BSA) as the standard. The b-lactamase activity was determined in 1 mL of 50 mM sodium phosphate buffer pH 7.0, at 308C observing the hydrolysis rate of cefotaxime (100 mM). One unit of b-lactamase activity was defined as the amount of the enzyme that hydrolyses 1 mmol of the substrate/min.
Molecular weight and isoelectric point determination
The molecular weight was determined by SDS-PAGE, 21 using a Mini-protean II electrophoresis system (Bio-Rad Laboratories, Richmond, CA, USA). Proteins were detected by staining the gel with Coomassie Brilliant Blue. 20 Isoelectric focusing was carried out with a Multiphor II electrophoresis system (Pharmacia Biotech, Uppsala, Sweden) and a gel plate containing 5% Ampholine ( pH range 3.5-9.5). Isoelectric point was determined by focusing 20 mg of purified enzyme. b-Lactamase activity was detected by zymogram technique using 250 mM nitrocefin.
Determination of kinetic parameters
Kinetic parameters of CTX-M-43 were determined by monitoring the variation in the absorbance of b-lactam antibiotics in 50 mM phosphate buffer (pH 7.0). All measurements were made with a microcomputer-linked Lambda 2 spectrophotometer (Applied Biosystems). The reactions were performed at 308C. BSA at 20 mg/L was added to the dilute solution of b-lactamase to prevent denaturation. For the compounds behaving as substrates, the steady-state kinetic parameters, K m and k cat , were determined by Hanes -Woolf linearization or by non-linear least-square fit of the MichaelisMenten equation. 22 -24 The reaction is described by the model:
For compounds rather stable to the action of the b-lactamase, the k cat values were determined from the initial rates calculated at saturating substrate concentrations, and the K m values were determined from experiments involving competition between the poor substrate and nitrocefin.
In compounds behaving as transient inactivators, a rather stable acyl-enzyme (ES*) was found to accumulate. The slow breakdown of ES*, due to a low value of k þ3 , regenerated the free enzyme. The values of the first-order rate constant K i , characterizing the rate of ES* accumulation, were derived from the hydrolysis curves of nitrocefin as a reporter substrate, at 482 nm. 25, 26 Alternatively, the k þ3 value was obtained by the direct hydrolysis of the poor substrate with large enzyme concentration. The hydrolysis rate was measured at the steady state. In that case, the k cat value was equal to k þ3 . 25, 26 In compounds behaving as inactivators, the k þ3 value was obtained by monitoring the reactivation of the enzyme in the presence of the reporter substrate. The enzyme was first completed inactivated and then a small proportion of the reaction mixture was diluted to reduce the inactivator concentration to a negligible value. 22, 26 The values of k þ2 and K were calculated by non-linear regression using the software LabPlot version 1.5.1. All measurements were made at least three times for each substrate, and reproducible results were obtained.
Molecular modelling
In order to provide qualitative insights into the structural features of the Michaelis complex of some of the investigated antibiotics, Molecular Mechanic calculations using GROMACS 27 package with GROMOS96 28 force fields were carried out. For this purpose, the crystal structure of the acyl-enzyme CTX-M-44 Glu-166!Ala mutant (PDB code, 1IYO), 9 in complex with cefotaxime, was used as a template. The aspartate residue at position 240 was mutated into a glycine residue using the MOLDEN program. A first potential energy minimization was carried out using the steepest descent algorithm. Then, a short (200 ps) molecular dynamics simulation was performed at 300 K in order to carry out a local search of the most stable structure. As this analysis is only mechanical, the most stable structure was defined as the one showing the lowest potential energy. The same procedure was repeated for the Michaelis complex with ceftazidime and ceftibuten. The results outlined in this article refer to the most stable structures.
Results and discussion
As shown in Table 1 , the A. baumannii clinical isolate showed resistance to almost all b-lactam antibiotics tested. However, it showed susceptibility to imipenem and meropenem and the MICs of amoxicillin and cefotaxime decreased in the presence of 4 mg/L clavulanic acid. Tazobactam at 4 mg/L was able to restore susceptibility to piperacillin.
CTX-M-43 was purified from E. coli BL21 pET-26(b)(þ)/ CTX-M-43 by two chromatographic steps, which yielded a protein pure at 95% as evaluated by the SDS-PAGE analysis. The apparent molecular weight estimated for the CTX-M-43 enzyme was $28 kDa, and the isoelectric point was determined at 7.8.
The steady-state kinetic parameters k cat and K m , determined for a set of substrates ( Table 2 ), indicate that CTX-M-43 b-lactamase hydrolyses all cephalosporins tested, including ceftazidime. Cefazolin is the best substrate for CTX-M-43 among first-generation cephalosporins, with a catalytic efficiency of 4.2 mM 21 /s. The k cat value for ceftazidime was not determined in our experimental condition, because of high K m value (1600 mM), even if a slight hydrolysis was detected. Ceftibuten, a non-oxyimino third-generation cephalosporin, and cefepime, a fourth-generation oxyimino cephalosporin, behaved as good substrates; for ceftibuten, it was possible to determine the kinetic parameters k cat and K m . Interestingly, monobactams such as aztreonam and carumonam behaved as good substrates, although aztreonam showed a better catalytic efficiency with respect to carumonam. With regard to moxalactam, an oxacephem, the K m value indicates a good affinity of the enzyme for this compound; however, the low catalytic efficiency observed is mainly due to the low k cat value, 6.0 Â 10 23 /s. Among all carbapenems tested (Table 3) , imipenem behaved as a transient inactivator, leading to the accumulation of a rather stable acyl-enzyme complex, with a very low deacylation constant (2.1 Â 10 24 /s) and a low acylation efficiency (84 M 21 /s). Meropenem and ertapenem were inactivators of CTX-M-43 with good acylation efficiencies (k þ2 /K), but with negligible deacylation constants (k þ3 ). In this respect, ertapenem showed the best acylation efficiency (3.0 Â 10 4 s 21 /M). Classical inhibitors of class A enzymes (Table 3) , sulbactam, tazobactam and clavulanate, acted as competitive inhibitors with K i values of 0.6, 0.5 and 37 mM, respectively. No direct hydrolysis of the inhibitors was detected in our experimental conditions. A general reduction in K m values was observed for some cephalosporins, comparing the kinetic parameters of CTX-M-43 with those of CTX-M-44, as shown in Table 2 .
This observation is in accordance with a general increase in affinity towards cephalosporins induced by the Asp-240!Gly substitution. 29 In CTX-M-43, a 4-fold decrease in K m and k cat for cefotaxime preserves the k cat /K m value from significant alterations. For ceftazidime, we report a 7-fold reduction in the K m value with respect to CTX-M-44. Unfortunately, under our experimental conditions, the high value of K m made the accurate determination of the k cat value difficult. Interestingly, a 10-fold increase in the catalytic efficiency is observed in CTX-M-43 towards the fourth-generation cephalosporin, cefepime. Class In order to confirm the observations achieved from kinetic experiments, MICs were determined for all the substrates at two different concentrations of the bacterial inoculum, 5 Â 10 5 and 5 Â 10 8 cfu/mL. E. coli HB101 pBC-SK(þ)/CTX-M-43 showed resistance to all cephalosporins tested. The MICs relative to monobactams seem to reflect the different activity of the enzyme towards those antibiotics. In fact, a lower catalytic efficiency against carumonam might have an influence on the MIC. For carbapenems, it was possible to observe that the increase in the bacterial inoculum had no effect on MICs of meropenem and ertapenem. These data seem to confirm that those compounds, acting as inactivators with a negligible k þ3 value, cannot be hydrolysed from CTX-M-43. Interestingly, imipenem behaved in a different way. In fact, increasing the bacterial inoculum, we observed an increase in the MIC value, from 0.25 to 1 mg/L. These data seem to be in agreement with the kinetic analysis performed, in which imipenem acted as a transient inactivator with a significant k þ3 value.
Structural information obtained from the crystal structure of Toho-1 acyl-intermediate in complex with cefotaxime showed that aspartate-240 residue might establish hydrogen bonds with the amino group of the aminothiazolic substituent of the acylcefotaxime intermediate. 8, 9, 11, 29 Thus, the aspartate-240 might be involved in the oxyimino-cephalosporinase activity by fixing cefotaxime in the binding site.
In order to investigate the effect of glycine residue at position 240, molecular modelling of the Michaelis complex of CTX-M-43 in combination with ceftazidime, cefotaxime and ceftibuten was performed by molecular mechanics calculations. The hypothesis that substitution of the charged and bulky aspartate with the neutral and small glycine residue might favour the accommodation of the C7b substituents of oxyimino cephalosporins in the catalytic site seems to be confirmed. Specifically, the molecular model of CTX-M-43 shows that glycine residue at position 240 allows a better accommodation of the bulky C7b side chains of ceftazidime, cefotaxime and ceftibuten by expansion of the binding site (Figure 1 ). The absence of the electrostatic interaction between aspartate-240 and the amino group of the aminothiazolic substituent and the expansion of the binding site result in the increased affinity of the enzyme versus all cephalosporins tested, as supported from kinetics data. Substitution Asp-240!Gly has never been observed in naturally occurring TEM and SHV. However, in a recent work, 18 we described the kinetic characterization of TEM-149, a naturally occurring Glu-240!Val mutant. In this enzyme, the catalytic efficiency versus ceftazidime increases as a result of the substitution of a charged and bulky residue with a hydrophobic residue.
Nowadays, it is quite clear that CTX-M-type enzymes represent a versatile and adaptable class of enzymes. The data collected in the present work from in vivo activity and kinetic analysis show how CTX-M-type enzymes appear to be evolving in response to the extensive use of cephalosporins in clinical therapy. At the same time, the detectable deacylation constant for imipenem, in addition to the high acylation efficiency for meropenem and ertapenem, and the increase in MICs in response to bacterial inoculum make plausible the potentiality, from an evolutionary standpoint, of those enzymes to converge in the direction of a possible carbapenemase activity.
Although all known class A carbapenemases are characterized for the presence of a disulphide bridge between the cysteine residues at positions 69 and 238, in CTX-M-43, the position 238 is occupied by a glycine. In fact, it is known that high flexibility of the b-strand B3, which contains the KTG-conserved motif, is one of the features contributing to the cephalosporinase activity of CTX-M enzymes. Ibuka et al. 30 showed that a disulphide bridge at this position decreases drastically the flexibility of the b-strand B3, significantly reducing the activity against thirdgeneration cephalosporins, whereas the catalytic efficiency against penicillins and first-generation cephalosporins was not affected. However, the carbapenemase activity of certain class A enzymes is the consequence of several strategic residues in combination with the presence of a disulphide bridge.
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